When a drug is administered to exert its efficacy, it will encounter multiple barriers and go
through multiple interactions. Predicting the drug-related multiple interactions is critical for …

Drug–drug interactions (DDI) are a critical aspect of drug research that can have adverse
effects on patients and can lead to serious consequences. Predicting these events …

Understanding drug–drug interactions is an essential step to reduce the risk of adverse drug
events before clinical drug co-prescription. Existing methods, commonly integrating …

In clinical treatment, two or more drugs (ie drug combination) are simultaneously or
successively used for therapy with the purpose of primarily enhancing the therapeutic …

Motivation: As concurrent use of multiple medications becomes ubiquitous among patients, it
is crucial to characterize both adverse and synergistic interactions between drugs. Statistical …

Exploring drug–target interactions by biomedical experiments requires a lot of human,
financial, and material resources. To save time and cost to meet the needs of the present …

Polypharmacy, the co-administration of multiple drugs, has become an area of concern as
the elderly population grows and an unexpected infection, such as COVID-19 pandemic …

Background: The identification of drug-target interactions is a crucial issue in drug discovery.
In recent years, researchers have made great efforts on the drug-target interaction …

Drug–drug interactions play a vital role in drug research. However, they may also cause
adverse reactions in patients, with serious consequences. Manual detection of drug–drug …

Detecting drug–drug interactions (DDIs) is an essential step in drug development and drug
administration. Given the shortcomings of current experimental methods, the machine …